查看购物车
  • Traditional Chinese
  • English
  • Japanese
全球 CBD 宠物用品市场 - 2023-2030 年
市场调查报告书
商品编码
1319236

全球 CBD 宠物用品市场 - 2023-2030 年

Global CBD Pet Products Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概述

2022 年，全球 CBD 宠物用品市场规模达到 5.125 亿美元，预计到 2030 年将达到 29.583 亿美元，2023-2030 年的复合年增长率为 24.5%。

大麻二酚宠物产品市场是指专注于提供包含大麻二酚（CBD）的各种产品的行业，这些产品主要是为宠物配制的。大麻二酚是从大麻中提取的一种化合物，大麻二酚是大麻花的一种衍生物。大麻二酚以其潜在的治疗功效而闻名，并被用于旨在解决宠物众多健康问题的产品中。这些产品中使用的 CBD 来自大麻花，而大麻花中的 THC（大麻中的精神活性化合物）含量最低。

CBD 宠物产品不再局限于精油或酊剂。市场已经加速发展，包含了种类繁多的产品，如宠物食品、胶囊、外用药（乳液或药膏），甚至还有专门针对幼犬的 CBD 食品。产品服务的增长为宠物主人提供了更多的选择，主要是根据宠物的选择和愿望。

市场动态

消费者对使用 CBD 产品倾向的转变推动了 CBD 宠物用品市场的发展

随着时间的推移，消费者对 CBD 的看法也在发生变化。越来越多的人接受 CBD 是一种具有潜在健康益处的天然药物。这种观念的转变也延伸到了宠物主人身上，他们越来越愿意为自己的宠物探索 CBD 产品，从而推动了对 CBD 宠物产品的需求。例如，宠物补充剂制造商 NaturVet 是亚马逊上该类产品的销量冠军，月收入达 100 万美元。

为宠物使用过 CBD 产品的宠物主人所分享的积极经验和见证在推动消费者倾向于使用 CBD 宠物产品方面发挥了重要作用。个人经历和口碑推荐会让其他宠物主人了解并产生兴趣，从而增加需求。

CBD产品的创新有望促进CBD宠物产品市场的发展

CBD 宠物产品的创新包括开发新的、多样化的产品选择。这包括添加了 CBD 的食物、精油、胶囊、外用药等。通过提供多种产品，市场可以满足不同宠物的喜好和健康需求，扩大客户群，促进市场增长。例如，品牌 Innovative 提供 CBD + CBDa 配方，这是一种独特的 CBD 和其他大麻素混合配方，共同发挥最大功效。

CBD 宠物产品侧重于有针对性的配方，以解决宠物的特定健康问题。例如，针对关节健康、焦虑缓解或皮肤状况的产品可为宠物主人提供量身定制的解决方案。有针对性的配方提高了 CBD 宠物产品的有效性和吸引力，推动了市场的增长。

CBD 产品监管的不确定性阻碍了 CBD 宠物用品市场的发展

各辖区监管不明确或监管不一致会阻碍 CBD 宠物产品的市场扩张。如果没有明确的指导方针，企业在进入新市场或扩大产品供应方面就会面临挑战，从而减少增长机会。监管的不确定性会使兽医专业人士在推荐或认可 CBD 宠物产品时犹豫不决。兽医依赖于明确的指导方针来确保他们向宠物主人推荐的产品的安全性和有效性。缺乏明确的监管规定会导致人们采取谨慎的态度，阻碍CBD宠物产品被更广泛地接受和采用。

法规不明确会削弱消费者对 CBD 宠物产品的信心和信任。在没有标准化法规的情况下，消费者可能会担心这些产品的安全性、质量和可靠性。这种信心的缺乏会减缓市场增长，限制消费者尝试CBD宠物产品的意愿。

COVID-19 影响分析

COVID-19 分析包括 COVID 前情景、COVID 情景和 COVID 后情景，以及定价动态（包括大流行期间和大流行后的定价变化，并与 COVID 前情景进行比较）、供求光谱（由于贸易限制、封锁和后续问题而导致的供求变化）、政府倡议（政府机构为振兴市场、部门或行业而采取的倡议）和制造商战略倡议（此处将涵盖制造商为缓解 COVID 问题而采取的措施）。

目 录

第 1 章：研究方法与范围

  • 研究方法
  • 报告的研究目标和范围

第2章：市场定义与概述

第3章：执行摘要

  • 按类型分類的市场摘要
  • 按销售渠道分類的市场摘要
  • 按地区分類的市场摘要

第 4 章：市场动态

  • 市场影响因素
    • 驱动因素
    • 限制因素
    • 机会
    • 影响分析

第 5 章：行业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章：COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的情况
    • COVID-19 期间的情景
    • COVID-19 之后的情况
  • COVID-19 期间的定价动态
  • 供求关系
  • 大流行期间与市场相关的政府倡议
  • 制造商的战略倡议
  • 结论

第七章：按类型划分

  • 食品级
  • 治疗级

第 8 章：按分销渠道

  • 零售药店
  • 在线销售
  • 兽医诊所
  • 其他

第 9 章：按地区划分

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 合併与收购分析

第 11 章 ：公司简介

  • GCH, Inc.
    • 公司概况
    • 产品组合和说明
    • 财务概况
    • 主要发展
  • Canna-Pet
  • Honest Paws
  • HempMy Pet
  • Fomo Bones
  • HolistaPet
  • Pet Releaf
  • Joy Organics
  • Petco Animal Supplies, Inc.
  • Charlotte's Web

第 12 章 ：附录

简介目录
Product Code: FB6590

Market Overview

Global CBD Pet Products Market reached US$ 512.5 million in 2022 and is expected to reach US$ 2,958.3 million by 2030 growing with a CAGR of 24.5% during the forecast period 2023-2030.

The CBD pet products market refers to the industry focused on offering various products that include cannabidiol (CBD) mainly formulated for pets. Cannabidiol is a compound derived from hemp, a ramification of hashish flowers. CBD is known for its potential therapeutic benefits and is utilized in products designed to address numerous fitness concerns in pets. The CBD utilized in these products is sourced from hemp flowers, which include minimum tiers of THC, the psychoactive compound found in hashish.

CBD pet products are no longer limited to just oils or tinctures. The market has accelerated to include a huge variety of products such as treats, capsules, topicals (lotions or balms), and even puppy-specific CBD-infused foods. This growth of product services affords pet owners with more alternatives to choose from primarily based on their pets' choices and desires.

Market Dynamics

Shifting Consumer Inclination Toward the Usage of CBD Products is Driving the CBD Pet Products Market

Consumer perception of CBD has been changing over time. There is a growing acceptance of CBD as a natural remedy with potential health benefits. This shifting perception extends to pet owners who are becoming more open to exploring CBD products for their pets, driving the demand for CBD pet products. For instance, pet supplement manufacturer NaturVet is the top seller in the category on Amazon with monthly revenue of $1 million.

The positive experiences and testimonials shared by pet owners who have used CBD products for their pets play a significant role in driving consumer inclination towards CBD pet products. Personal stories and word-of-mouth recommendations create awareness and generate interest among other pet owners, leading to increased demand.

Innovation in CBD Products is Expected to Foster the CBD Pet Products Market

Innovation in CBD pet products involves the development of new and diverse product options. This includes CBD-infused treats, oils, capsules, topicals, and more. By offering a wide range of products, the market can cater to different pet preferences and health needs, expanding the customer base and fostering market growth. For instance, the brand Innovative offers CBD + CBDa formula, which is a unique blend of CBD and other cannabinoids that work together to provide the maximum benefits.

CBD pet products focus on targeted formulations that address specific health concerns in pets. For example, products formulated for joint health, anxiety relief, or skin conditions provide tailored solutions for pet owners. Targeted formulations enhance the effectiveness and appeal of CBD pet products, driving the market growth.

Regulatory Uncertainty of CBD Products is Holding Back the CBD Pet Products Market

Regulatory ambiguity or inconsistent regulations across jurisdictions can hinder market expansion for CBD pet products. Without clear guidelines, businesses face challenges in entering new markets or expanding their product offerings, reducing growth opportunities. Regulatory uncertainty can create hesitation among veterinary professionals in recommending or endorsing CBD pet products. Veterinarians rely on clear guidelines to ensure the safety and efficacy of products they recommend to pet owners. The lack of regulatory clarity can lead to a cautious approach, hindering wider acceptance and adoption of CBD pet products.

Unclear regulations can undermine consumer confidence and trust in CBD pet products. Consumers may be concerned about the safety, quality, and reliability of these products without standardized regulations in place. This lack of confidence can slow down market growth and limit consumer willingness to try CBD pet products.

COVID-19 Impact Analysis

The COVID-19 Analysis includes Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it with pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown, and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).

Segment Analysis

The global CBD pet products market is segmented based on product, distribution channel, and region.

By Distribution Channel, the Retail Pharmacies Segment is Estimated to have Significant Growth During the Forecast Period

Retail pharmacies have been gradually accepting and stocking CBD products, including CBD pet products, in response to growing consumer demand. This increased acceptance and availability of CBD pet products in retail pharmacies contribute to their potential for significant growth in this segment. For instance, according to an article published by PPSC Pharmacies, by 2024, CBD will be a 20-billion-dollar industry. This is a perfect opportunity for pharmacies to tap into a product that can not only increase patient outcomes but also their cash profits.

Retail pharmacies have an established distribution network that reaches a wide range of customers. This network allows CBD pet products to be readily accessible to pet owners who visit pharmacies for their own health and wellness needs. The existing infrastructure and reach of retail pharmacies provide a strong foundation for growth in this segment.

Geographical Analysis

Asia Pacific is the Fastest Growing Market in the CBD Pet Products Market

Asia Pacific is home to a large population and a growing middle class with growing disposable income. This demographic shift has brought about a upward push in pet ownership and an increased attention on pet fitness and properly-being. The increasing pet market within the Asia Pacific gives massive increase possibilities for CBD puppy products.

The awareness and acceptance of CBD products, including CBD pet products, are steadily growing inside the Asia Pacific region. As facts and education approximately CBD and its capability advantages come to be more on hand, pet owners have become extra open to exploring CBD as an choice for their pets' health concerns.

Competitive Landscape

The major global players in the market include: GCH, Inc., Canna-Pet, Honest Paws, HempMy Pet, Fomo Bones, HolistaPet, Pet Releaf, Joy Organics, Petco Animal Supplies, Inc., and Charlotte's Web.

Why Purchase the Report?

  • To visualize the global CBD pet products market segmentation based on type, distribution channel, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities in the market by analyzing trends and co-development.
  • Excel data sheet with numerous data points of CBD pet products market-level with all segments.
  • The PDF report consists of cogently put-together market analysis after exhaustive qualitative interviews and in-depth market study.
  • Product mapping is available as Excel consists of key products of all the major market players.

The global CBD pet products market report would provide approximately 53 tables, 47 figures and 190 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet, by Type
  • 3.2. Market Snippet, by Distribution Channel
  • 3.3. Market Snippet, by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19 on the Market
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Food-Grade*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Therapeutic-Grade

8. By Distribution Channel

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 8.1.2. Market Attractiveness Index, By Distribution Channel
  • 8.2. Retail Pharmacies*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Online Sales
  • 8.4. Veterinary Clinics
  • 8.5. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America*
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. The U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. The U.K.
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. GCH, Inc.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Canna-Pet
  • 11.3. Honest Paws
  • 11.4. HempMy Pet
  • 11.5. Fomo Bones
  • 11.6. HolistaPet
  • 11.7. Pet Releaf
  • 11.8. Joy Organics
  • 11.9. Petco Animal Supplies, Inc.
  • 11.10. Charlotte's Web

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us